# A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions

> **NCT03905564** · PHASE1 · WITHDRAWN · sponsor: **Grünenthal GmbH**

## Conditions studied

- Bioavailability

## Interventions

- **DRUG:** doxylamine succinate 10 mg/pyridoxine hydrochloride 10 mg combination
- **DRUG:** Diclegis (Registered Trademark)

## Key facts

- **NCT ID:** NCT03905564
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-06
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2019-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03905564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03905564, "A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03905564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*